Stockscreener 앱 받기
0.09%
전일 마감가:
$271.90
열려 있는:
$269.48
하루 거래량:
2.53M
Relative Volume:
0.84
시가총액:
$146.07B
수익:
$34.13B
순이익/손실:
$5.93B
주가수익비율:
24.79
EPS:
10.96
순현금흐름:
$10.92B
1주 성능:
-0.28%
1개월 성능:
-2.25%
6개월 성능:
-7.76%
1년 성능:
-11.37%
1일 변동 폭
$269.13
$272.52
1주일 범위
$269.10
$276.90
52주 변동 폭
$253.30
$346.85
암젠 Stock (AMGN) Company Profile
명칭
Amgen Inc
전화
(805)447-1000
주소
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
AMGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
271.66 | 146.48B | 34.13B | 5.93B | 10.92B | 10.96 |
|
LLY
Lilly Eli Co
|
713.71 | 679.94B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
152.94 | 364.11B | 89.33B | 21.81B | 18.57B | 8.99 |
|
ABBV
Abbvie Inc
|
183.26 | 325.05B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
112.75 | 216.45B | 53.22B | 12.86B | 14.85B | 6.39 |
|
NVO
Novo Nordisk Adr
|
67.35 | 286.02B | 43.59B | 15.04B | 10.74B | 3.3766 |
암젠 Stock (AMGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-20 | 재개 | Guggenheim | Neutral |
| 2025-04-22 | 재개 | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-14 | 개시 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Outperform |
| 2024-10-14 | 다운그레이드 | Truist | Buy → Hold |
| 2024-09-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-05-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 재개 | Raymond James | Mkt Perform |
| 2024-02-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-11-02 | 업그레이드 | Truist | Hold → Buy |
| 2023-10-20 | 재개 | JP Morgan | Neutral |
| 2023-10-17 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 재개 | BofA Securities | Neutral |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-04-24 | 재확인 | Oppenheimer | Outperform |
| 2023-03-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 재확인 | Truist | Buy |
| 2022-11-18 | 개시 | Credit Suisse | Underperform |
| 2022-10-31 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-10-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-02-09 | 재확인 | Barclays | Equal Weight |
| 2022-02-09 | 재확인 | Jefferies | Buy |
| 2022-02-09 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 재확인 | Oppenheimer | Outperform |
| 2022-02-09 | 재확인 | Wells Fargo | Equal Weight |
| 2022-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-12-09 | 재개 | Wells Fargo | Equal Weight |
| 2021-12-06 | 개시 | Goldman | Buy |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-09-23 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 개시 | Daiwa Securities | Buy |
| 2020-10-28 | 개시 | UBS | Neutral |
| 2020-10-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | 업그레이드 | Truist | Hold → Buy |
| 2020-10-09 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | 다운그레이드 | Truist | Buy → Hold |
| 2020-10-08 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 재개 | Guggenheim | Neutral |
| 2020-03-31 | 개시 | Wolfe Research | Peer Perform |
| 2020-03-30 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-01-31 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 개시 | Raymond James | Mkt Perform |
| 2019-12-17 | 재개 | Morgan Stanley | Overweight |
| 2019-11-12 | 개시 | SunTrust | Buy |
| 2019-11-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-19 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2019-05-23 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
암젠 주식(AMGN)의 최신 뉴스
Zacks Research Has Bullish Outlook for Amgen FY2025 Earnings - MarketBeat
Parr Mcknight Wealth Management Group LLC Takes $3.75 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
4,827 Shares in Amgen Inc. (NASDAQ:AMGN) Acquired by Pacific Point Advisors LLC - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Western Wealth Management LLC - MarketBeat
JT Stratford LLC Sells 1,223 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Valueworks LLC Sells 1,922 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
USS Investment Management Ltd Cuts Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
With 81% institutional ownership, Amgen Inc. (NASDAQ:AMGN) is a favorite amongst the big guns - Yahoo Finance
Blue Fin Capital Inc. Buys 1,431 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
The Smartest High-Yielding Dividend Stocks in the Nasdaq Composite Index to Buy With $1,500 Right Now - The Motley Fool
Focus Partners Advisor Solutions LLC Purchases 2,264 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp - MarketBeat
Worldquant Millennium Advisors LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Holdings Raised by Twinbeech Capital LP - MarketBeat
Lazard Asset Management LLC Cuts Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Siemens Fonds Invest GmbH Sells 22,764 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen’s Enbrel Targeted as Colorado Panel Works on Payment Cap - Bloomberg Law News
Wall Street Zen Upgrades Amgen (NASDAQ:AMGN) to Strong-Buy - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Two Sigma Advisers LP - MarketBeat
Nephrology Drugs Market in 2025 Detailed Study Analysis | Amgen Inc., F. Hoffmann-La Roche Ltd, Sanofi, Novartis AG - openPR.com
The Zacks Analyst Blog Highlights Eli Lilly, GE Aerospace and Amgen - Yahoo Finance
35,409 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by Ames National Corp - MarketBeat
Zurich Insurance Group Ltd FI Trims Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Westwood Holdings Group Inc. Has $3.12 Million Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen (NASDAQ:AMGN) Stock Acquired Rep. Marjorie Taylor Greene - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Silvercrest Asset Management Group LLC - MarketBeat
Litigators of the Week: A $406.8M Win for Regeneron in Antitrust Trial Showdown With Cholesterol Drug Rival Amgen - Law.com
Top Analyst Reports for Eli Lilly, GE Aerospace & Amgen - Yahoo Finance
Better Weight Loss Stock: Amgen or Viking Therapeutics? - Yahoo Finance
White Knight Strategic Wealth Advisors LLC Acquires 3,941 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen And Samsung Soliris Biosimilars Skirt UK Infringement On Claim Construction - insights.citeline.com
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Voloridge Investment Management LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Williams Jones Wealth Management LLC. - MarketBeat
Woodline Partners LP Has $93.59 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Tidal Investments LLC Boosts Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Toronto Dominion Bank Sells 50,199 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc.: What Is Its Commercial Strategy For UPLIZNA In New Indications? - Smartkarma
Sanofi makes $470M move for Vigil's Alzheimer's drug, while another asset returns to Amgen - Endpoints News
Shell Asset Management Co. Sells 3,701 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
On the Global Stage: Amgen’s Top Voices Drive Conversations on AI and Innovation - Amgen
Amgen at RBC Capital Markets: Strong Start and Strategic Focus - Investing.com
Amgen at RBC Capital Markets: Strong Start and Strategic Focus By Investing.com - Investing.com India
Transcript : Amgen Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-21-2025 09 - marketscreener.com
AMGN Down 10% in 3 Months: How to Play the Stock as Tariff Woes Linger - TradingView
Vivaldi Capital Management LP Grows Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
St. Clair Advisors LLC Takes $730,000 Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
4,500 Shares in Amgen Inc. (NASDAQ:AMGN) Bought by Triglav Skladi D.O.O. - MarketBeat
Two Sigma Investments LP Increases Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Sen. Tommy Tuberville Sells Amgen Inc. (NASDAQ:AMGN) Stock - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Polar Capital Holdings Plc - MarketBeat
암젠 (AMGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.67%
0.59%
자본화:
|
볼륨(24시간):